Skip to main content

Together we are beating cancer

Donate now

Justine Alford

Justine studied biological sciences at the University of Warwick before diving straight into a PhD at the same institution, working on how HIV hijacks certain transport pathways in cells. After subsequently working as a science writer for several years, Justine joined the Science Communications team at Cancer Research UK in 2016, helping communicate research on cancer to the public and media.
Showing 12 out of 81 results

Our new research partnership is exploring common ground between arthritis and cancer, which could bring benefits to patients on both sides. Our new research partnership is exploring common ground between arthritis and cancer, which could bring benefits to patients on both sides.

by Justine Alford | Analysis | 4 March 2018

4 March 2018

This week's news features over-egged claims of a cancer vaccine and fears over suggested links between ‘ultra-processed’ foods and cancer. This week's news features over-egged claims of a cancer vaccine and fears over suggested links between ‘ultra-processed’ foods and cancer.

by Justine Alford | Analysis | 17 February 2018

17 February 2018

Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients? Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients?

by Justine Alford | Analysis | 7 February 2018

7 February 2018

This entry is part 6 of 23 in the series Science Surgery

This week’s news features a promise of over 5000 extra staff to tackle NHS shortages, and a ground-breaking personalised medicine trial for pancreatic cancer. This week’s news features a promise of over 5000 extra staff to tackle NHS shortages, and a ground-breaking personalised medicine trial for pancreatic cancer.

by Justine Alford | Analysis | 9 December 2017

9 December 2017

Will personalised medicine become the norm of cancer treatment? In this Science Surgery instalment, we asked experts for their thoughts on this question. Will personalised medicine become the norm of cancer treatment? In this Science Surgery instalment, we asked experts for their thoughts on this question.

by Justine Alford | Analysis | 14 November 2017

14 November 2017

This entry is part 5 of 23 in the series Science Surgery

Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier. Our top stories this week: testosterone levels and prostate cancer risk, new cervical screening research and detecting oesophageal cancer earlier.

by Justine Alford | Analysis | 11 November 2017

11 November 2017

In our round-up of this year's NCRI conference we reveal exciting new research that's helping scientists get to know cancer better. In our round-up of this year's NCRI conference we reveal exciting new research that's helping scientists get to know cancer better.

by Justine Alford | Analysis | 8 November 2017

8 November 2017